CytoDyn Inc.
CytoDyn Inc. (CYDY) Stock Overview
Explore CytoDyn Inc.’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
351.9M
P/E Ratio
-9.05
EPS (TTM)
$-0.03
ROE
0.38%
CYDY Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of CytoDyn Inc. (CYDY) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 60.27, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.33.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -9.05 and a market capitalization of 351.9M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.